Cristina
Martín Higueras
Investigadora en el periodo 2020-2022
![Foto de Cristina](/img/uploaded/87B6C112361C9D83C89B5AD420E12B43.jpg)
![Foto de Hospital Universitario de Canarias](/img/noimage_org.png)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (8)
2024
-
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1
Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133
2023
-
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
Kidney International Reports, Vol. 8, Núm. 10, pp. 2029-2042
2019
-
Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1
Nucleic Acid Therapeutics, Vol. 29, Núm. 2, pp. 104-113
2018
-
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Nature Communications, Vol. 9, Núm. 1
-
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1
Journal of Medicinal Chemistry, Vol. 61, Núm. 16, pp. 7144-7167
-
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
Molecular Therapy, Vol. 26, Núm. 8, pp. 1983-1995
2017
-
Molecular therapy of primary hyperoxaluria
Journal of Inherited Metabolic Disease, Vol. 40, Núm. 4, pp. 481-489
2016
-
Iohexol plasma clearance, a simple and reliable method to measure renal function in conscious mice
Pflugers Archiv European Journal of Physiology, Vol. 468, Núm. 9, pp. 1587-1594